WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ocular Therapeutix earnings were -$249.7M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest OCUL earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$69.4M, up 2.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OCUL reported annual earnings of -$193.5M, with 139.7% growth.

OCUL earnings history

Current Revenue
$55.8M
Current Earnings
-$249.7M
Current Profit Margin
-447.6%

OCUL Return on Equity

Current Company
-87.2%
Current Industry
-21.3%
Current Market
35.2%
OCUL's Return on Equity (-87.2%)... subscribe to Premium to read more.
High Return on Equity Performance

OCUL undefined

Current Company
-57.9%
Current Industry
-8.8%
OCUL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OCUL announces earnings.

OCUL undefined

Current Company
-65.7%
Current Industry
-3.4%
OCUL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OCUL vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OCUL-$233.54M-$249.67MN/A-$1.43
TVTX-$22.58M-$88.54MN/A-$1.03
VRDN-$299.04M-$301.97MN/A-$2.30
KNSA$53.58M$35.92M-91.34%$0.49
TLX$58.49M$31.40MN/AN/A
View Top Biotech Stocks

Ocular Therapeutix Earnings Reports & History FAQ

What were Ocular Therapeutix's earnings last quarter?

On OCUL's earnings call on Invalid Date, Ocular Therapeutix (NASDAQ: OCUL) reported Q3 2025 earnings per share (EPS) of -$0.38, up 72.73% year over year. Total OCUL earnings for the quarter were -$69.42 million. In the same quarter last year, Ocular Therapeutix's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.

Is Ocular Therapeutix profitable or losing money?

As of the last Ocular Therapeutix earnings report, Ocular Therapeutix is currently losing money. Ocular Therapeutix's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$249.67 million, a 43.21% increase year over year.

What was OCUL's earnings growth in the past year?

As of Ocular Therapeutix's earnings date in Invalid Date, Ocular Therapeutix's earnings has grown year over year. OCUL earnings in the past year totalled -$249.67 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.